Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Go back to Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
(NASDAQ: CMND) Delayed: 0.99 -0.17 (14.66%)
Previous Close $1.16    52 Week High
Open $1.15    52 Week Low
Day High $1.15    P/E N/A 
Day Low $0.92    EPS
Volume 1,917,560